Robot-induced hallucinations in Parkinson's disease depend on altered sensorimotor processing in fronto-temporal network.


Journal

Science translational medicine
ISSN: 1946-6242
Titre abrégé: Sci Transl Med
Pays: United States
ID NLM: 101505086

Informations de publication

Date de publication:
28 04 2021
Historique:
received: 16 05 2020
revised: 18 08 2020
accepted: 23 01 2021
entrez: 29 4 2021
pubmed: 30 4 2021
medline: 13 7 2021
Statut: ppublish

Résumé

Hallucinations in Parkinson's disease (PD) are disturbing and frequent non-motor symptoms and constitute a major risk factor for psychosis and dementia. We report a robotics-based approach applying conflicting sensorimotor stimulation, enabling the induction of presence hallucinations (PHs) and the characterization of a subgroup of patients with PD with enhanced sensitivity for conflicting sensorimotor stimulation and robot-induced PH. We next identify the fronto-temporal network of PH by combining MR-compatible robotics (and sensorimotor stimulation in healthy participants) and lesion network mapping (neurological patients without PD). This PH-network was selectively disrupted in an additional and independent cohort of patients with PD, predicted the presence of symptomatic PH, and associated with cognitive decline. These robotics-neuroimaging findings extend existing sensorimotor hallucination models to PD and reveal the pathological cortical sensorimotor processes of PH in PD, potentially indicating a more severe form of PD that has been associated with psychosis and cognitive decline.

Identifiants

pubmed: 33910980
pii: 13/591/eabc8362
doi: 10.1126/scitranslmed.abc8362
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Auteurs

Fosco Bernasconi (F)

Laboratory of Cognitive Neuroscience, Center for Neuroprosthetics & Brain Mind Institute, Ecole Polytechnique Fédérale de Lausanne (EPFL), 1202 Geneva, Switzerland.

Eva Blondiaux (E)

Laboratory of Cognitive Neuroscience, Center for Neuroprosthetics & Brain Mind Institute, Ecole Polytechnique Fédérale de Lausanne (EPFL), 1202 Geneva, Switzerland.

Jevita Potheegadoo (J)

Laboratory of Cognitive Neuroscience, Center for Neuroprosthetics & Brain Mind Institute, Ecole Polytechnique Fédérale de Lausanne (EPFL), 1202 Geneva, Switzerland.

Giedre Stripeikyte (G)

Laboratory of Cognitive Neuroscience, Center for Neuroprosthetics & Brain Mind Institute, Ecole Polytechnique Fédérale de Lausanne (EPFL), 1202 Geneva, Switzerland.

Javier Pagonabarraga (J)

Movement Disorders Unit, Neurology Department, Sant Pau Hospital, 08041 Barcelona, Spain.
Universitat Autònoma de Barcelona (UAB), 08193 Barcelona, Spain.
Centro de Investigación en Red-Enfermedades Neurodegenerativas (CIBERNED), 28031 Madrid, Spain.
Biomedical Research Institute (IIB-Sant Pau), 08041 Barcelona, Spain.

Helena Bejr-Kasem (H)

Movement Disorders Unit, Neurology Department, Sant Pau Hospital, 08041 Barcelona, Spain.
Universitat Autònoma de Barcelona (UAB), 08193 Barcelona, Spain.
Centro de Investigación en Red-Enfermedades Neurodegenerativas (CIBERNED), 28031 Madrid, Spain.
Biomedical Research Institute (IIB-Sant Pau), 08041 Barcelona, Spain.

Michela Bassolino (M)

Laboratory of Cognitive Neuroscience, Center for Neuroprosthetics & Brain Mind Institute, Ecole Polytechnique Fédérale de Lausanne (EPFL), 1202 Geneva, Switzerland.

Michel Akselrod (M)

Laboratory of Cognitive Neuroscience, Center for Neuroprosthetics & Brain Mind Institute, Ecole Polytechnique Fédérale de Lausanne (EPFL), 1202 Geneva, Switzerland.
MySpace Lab, Lausanne University UNIL and University Hospital of Lausanne, CHUV, 1011 Lausanne, Switzerland.

Saul Martinez-Horta (S)

Movement Disorders Unit, Neurology Department, Sant Pau Hospital, 08041 Barcelona, Spain.
Universitat Autònoma de Barcelona (UAB), 08193 Barcelona, Spain.
Centro de Investigación en Red-Enfermedades Neurodegenerativas (CIBERNED), 28031 Madrid, Spain.
Biomedical Research Institute (IIB-Sant Pau), 08041 Barcelona, Spain.

Frederic Sampedro (F)

Movement Disorders Unit, Neurology Department, Sant Pau Hospital, 08041 Barcelona, Spain.
Universitat Autònoma de Barcelona (UAB), 08193 Barcelona, Spain.
Centro de Investigación en Red-Enfermedades Neurodegenerativas (CIBERNED), 28031 Madrid, Spain.
Biomedical Research Institute (IIB-Sant Pau), 08041 Barcelona, Spain.

Masayuki Hara (M)

Graduate School of Science and Engineering, Saitama University, 338-8570 Saitama, Japan.

Judit Horvath (J)

Department of Neurology, Geneva University Hospitals, 1205 Geneva, Switzerland.

Matteo Franza (M)

Laboratory of Cognitive Neuroscience, Center for Neuroprosthetics & Brain Mind Institute, Ecole Polytechnique Fédérale de Lausanne (EPFL), 1202 Geneva, Switzerland.

Stéphanie Konik (S)

Laboratory of Cognitive Neuroscience, Center for Neuroprosthetics & Brain Mind Institute, Ecole Polytechnique Fédérale de Lausanne (EPFL), 1202 Geneva, Switzerland.
MySpace Lab, Lausanne University UNIL and University Hospital of Lausanne, CHUV, 1011 Lausanne, Switzerland.

Matthieu Bereau (M)

Department of Neurology, Geneva University Hospitals, 1205 Geneva, Switzerland.
Department of Neurology, Besançon University Hospital, 25056 Besançon, France.

Joseph-André Ghika (JA)

Department of Neurology, Hôpital du Valais, 1951 Sion, Switzerland.

Pierre R Burkhard (PR)

Department of Neurology, Geneva University Hospitals, 1205 Geneva, Switzerland.

Dimitri Van De Ville (D)

Medical Image Processing Laboratory, Institute of Bioengineering, Ecole Polytechnique Fédérale de Lausanne (EPFL), 1202 Geneva, Switzerland.
Department of Radiology and Medical Informatics, University of Geneva, 1206 Geneva, Switzerland.

Nathan Faivre (N)

Laboratory of Cognitive Neuroscience, Center for Neuroprosthetics & Brain Mind Institute, Ecole Polytechnique Fédérale de Lausanne (EPFL), 1202 Geneva, Switzerland.
Univ. Grenoble Alpes, Univ. Savoie Mont Blanc, CNRS, LPNC, 38000 Grenoble, France.

Giulio Rognini (G)

Laboratory of Cognitive Neuroscience, Center for Neuroprosthetics & Brain Mind Institute, Ecole Polytechnique Fédérale de Lausanne (EPFL), 1202 Geneva, Switzerland.

Paul Krack (P)

Department of Neurology, Inselspital, University Hospital and University of Bern, 3010 Bern, Switzerland.

Jaime Kulisevsky (J)

Movement Disorders Unit, Neurology Department, Sant Pau Hospital, 08041 Barcelona, Spain. olaf.blanke@epfl.ch jkulisevsky@santpau.cat.
Universitat Autònoma de Barcelona (UAB), 08193 Barcelona, Spain.
Centro de Investigación en Red-Enfermedades Neurodegenerativas (CIBERNED), 28031 Madrid, Spain.
Biomedical Research Institute (IIB-Sant Pau), 08041 Barcelona, Spain.

Olaf Blanke (O)

Laboratory of Cognitive Neuroscience, Center for Neuroprosthetics & Brain Mind Institute, Ecole Polytechnique Fédérale de Lausanne (EPFL), 1202 Geneva, Switzerland. olaf.blanke@epfl.ch jkulisevsky@santpau.cat.
Department of Neurology, Geneva University Hospitals, 1205 Geneva, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH